Preliminary research point out conolidine could inhibit specific ion channels, decreasing neuronal excitability and limiting soreness signals. This system is especially relevant in neuropathic discomfort, where abnormal signaling brings about persistent pain. Moreover, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to suffering perception. Computation... https://popex271wro2.wikitron.com/user